Acquisition Completed

Isto Biologics acquisition of NovaBone Products

US$60m consideration

Announced Aug 2026 (approx.)

Advisers

NovaBone Products

Target

Not disclosed

Isto Biologics

Acquirer

Financial adviser
Target
NovaBone Products
Acquirer
Isto Biologics
Seller
Halma
Target based in
United States
Buyer based in
United States
Seller based in
United Kingdom
Completed
5 Aug 2026
Sector
Medtech
Tags
Medtech, Life Sciences

In the league tables

Similar deals

All medtech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.